MINNETONKA, MN – UnitedHealth Group (NYSE: NYSE:), a $558 billion healthcare giant currently trading near its 52-week high, has provided financial guidance for 2025 and forecasts significant earnings growth ahead of its annual results Investor conference planned for next week. According to InvestingPro’s data, the company continues to have a “GREAT” financial health score, underscoring its strong market position. The healthcare group expects 2025 revenue to be between $450 billion and $455 billion, with net income per share expected to be between $28.15 and $28.65 and adjusted net income per share expected to be between $29.50 and will be $30.00.

The restated figures do not include non-cash after-tax depreciation expense associated with acquisition-related intangible assets. Additionally, the company expects cash flow from operating activities to be between $32 billion and $33 billion for the year.

These forecasts compare to previously announced 2024 expectations, which forecast net income between $15.50 and $15.75 per share and adjusted net income at $27.50 to $27.75 per share became. The significant increase in 2025 guidance reflects the company’s confidence in its growth trajectory, supported by its consistent performance with revenue growth of 9.4% over the last twelve months. The company has also demonstrated its commitment to shareholder returns, increasing its dividend for 15 consecutive years.

UnitedHealth Group’s divisions, Optum and UnitedHealthcare, have contributed significantly to the company’s growth. Optum offers technology and data-enabled healthcare services, while UnitedHealthcare offers a full range of healthcare benefits.

The 2025 guidance was released alongside an announcement that the investor conference presentation and a question-and-answer session with management will be streamed on the company’s investor relations website. Materials and a recording of the conference will also be available on the website.

This financial forecast is based on current market conditions and certain assumptions about UnitedHealth Group’s business and economics. Like all forward-looking statements, they are subject to risks and uncertainties that could cause actual results to differ materially. However, analysts remain bullish on UNH. Comprehensive analysis is available in InvestingPro’s detailed research reports, which provide deeper insights into the company’s valuation and growth prospects among over 1,400 top US stocks.

Investors and stakeholders are reminded that this information, including forward-looking statements and financial projections, is based on a UnitedHealth Group press release and should be evaluated as such.

In other recent news, UnitedHealth Group announced a December dividend of $2.10 per share. The company’s third-quarter revenue reached $101 billion, up 9%, and UnitedHealthcare added over 2.4 million members. However, several financial firms, including TD Cowen, KeyBanc and RBC Capital, adjusted their price targets for UnitedHealth following these earnings results. TD Cowen raised its price target, citing confidence in the healthcare giant’s future financial performance, while KeyBanc and RBC Capital lowered their price target, citing higher medical costs and 2025 earnings per share (EPS) that fell short of expectations. Additionally, UnitedHealth experienced a significant data breach affecting the personal information of approximately 100 million individuals. Finally, analysts predict that the upcoming US presidential election could have a potential impact on various sectors, including healthcare, with UnitedHealth potentially benefiting from possible tax cuts and deregulation. These are all current developments regarding UnitedHealth Group.

This article was created with the assistance of AI and reviewed by an editor. Further information can be found in our terms and conditions.